Insights Ahead: Relmada Therapeutics's Quarterly Earnings

Relmada Therapeutics RLMD is gearing up to announce its quarterly earnings on Thursday, 2025-03-27. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Relmada Therapeutics will report an earnings per share (EPS) of $-0.58.

Relmada Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

The company's EPS missed by $0.08 in the last quarter, leading to a 0.61% increase in the share price on the following day.

Here's a look at Relmada Therapeutics's past performance and the resulting price change:

Relmada Therapeutics Share Price Analysis

Shares of Relmada Therapeutics were trading at $0.3204 as of March 25. Over the last 52-week period, shares are down 93.4%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Relmada Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.